Suven gets product patent for neurological drug
The patents are valid till 2034
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Clariant launches packaging solutions for probiotics
The shelf life of probiotics in nutraceutical products is extended by inhibiting their exposure to damaging oxygen, moisture and…
Pharma exports declined by 4 per cent up to Aug on pricing pressure
Udaya Bhaskar, Director General, Pharmexcil hopes that the overall exports will recover and come into positive zone for the full…
PPS to expand API manufacturing capabilities in Asia and North America
Announces investments worth $55 million
Vice President inaugurates third International Conference on Yoga
The theme of this year’s conference will be ‘Yoga for Wellness’
Vice President, M Venkaiah Naidu inaugurated the two-day…
Marksans Pharma gets EIR from US FDA for its Goa facility
EIR is issued to a company detailing inspectional findings
Lupin receives FDA approval for generic Corgard Tablets
Nadolol Tablets are indicated for management of patients with angina pectoris and for the treatment of hypertension
Intas Pharma brings down cancer treatment cost by 60%
Bevacizumab is used in treating multiple-cancers like colorectal cancer, ovarian cancer, cervical cancer, lung cancer and…
SPARC’s Baclofen GRS fails to meet primary end point in placebo controlled studies
The study consisted of a total of 293 subjects in the intent to treat population
IIT Roorkee scientists identify drug to fight Chikungunya virus
The molecular details revealed in the study can be further utilised to design piperazine derivative drugs that are more potent and…
Granules India gets EIR from USFDA for OmniChem facility
OmniChem facility is operated by 50:50 joint venture of Granules India and Ajinimoto OmniChem
Novartis divests anti-infectives brands to Samara Capital
The portfolio of brands acquired focus on anti-infectives largely catering to the women's health and gynaecology segment
Fosun Pharma acquires 74 per cent stake in Gland Pharma for $1.09 bn
Following the completion of the acquisition, Gland Pharma has become an indirect non-wholly owned subsidiary of Fosun Pharma and…
MoH&FW to introduce new TB drug in controlled manner
As a pilot, 400 courses of Delamanid will be rolled out in five to six states as part of the conditional access programme under…
Aptar Pharma to highlight key innovations in drug delivery at CPHI Worldwide
The company will present three pharma insight briefings that will highlight its latest innovations and developments in the…
7th NGBT conference held in Bhubaneswar
The conference featured developments in genomics technologies and their applications in life sciences
Eris Lifesciences acquires UTH Healthcare
The amount of acquisition is Rs 12.85 crore
Zydus gets US FDA nod to market anti-diuretic nasal spray
The product will be manufactured at the group’s formulations manufacturing facility at Moraiya in Ahmedabad
Natco’s marketing partner Mylan gets US FDA nod for multiple sclerosis drug
The launch plans for both will be communicated shortly after concurring with its partner Mylan
Lonza to acquire US clinical manufacturing site
Site is being acquired from Shire and adds early-phase clinical manufacture on the West Coast